Biomedical Discovery Agents Connect Models and Evidence

Projection: Scientific agents will connect molecular simulators, structure models, experimental results, and literature into inspectable research trails that suggest the next calculation or assay. The opportunity is a discovery workspace, not a rare-disease caseboard. Microsoft's AI-for-science programs and AlphaFold's experimental impact make the integration plausible without proving autonomous discovery.